1G83 image
Deposition Date 2000-11-16
Release Date 2001-05-30
Last Version Date 2024-02-07
Entry Detail
PDB ID:
1G83
Keywords:
Title:
CRYSTAL STRUCTURE OF FYN SH3-SH2
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.27
R-Value Work:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:PROTO-ONCOGENE TYROSINE-PROTEIN KINASE FYN
Gene (Uniprot):FYN
Mutagens:C238S, C239S, C245S
Chain IDs:A, B
Chain Length:165
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
The role of the Src homology 3-Src homology 2 interface in the regulation of Src kinases.
J.Biol.Chem. 276 17199 17205 (2001)
PMID: 11278857 DOI: 10.1074/jbc.M011185200

Abstact

The regulatory fragment of Src kinases, comprising Src homology (SH) 3 and SH2 domains, is responsible for controlled repression of kinase activity. We have used a multidisciplinary approach involving crystallography, NMR, and isothermal titration calorimetry to study the regulatory fragment of Fyn (FynSH32) and its interaction with a physiological activator: a fragment of focal adhesion kinase that contains both phosphotyrosine and polyproline motifs. Although flexible, the preferred disposition of SH3 and SH2 domains in FynSH32 resembles the inactive forms of Hck and Src, differing significantly from LckSH32. This difference, which results from variation in the SH3-SH2 linker sequences, will affect the potential of the regulatory fragments to repress kinase activity. This surprising result implies that the mechanism of repression of Src family members may vary, explaining functional distinctions between Fyn and Lck. The interaction between FynSH32 and focal adhesion kinase is restricted to the canonical SH3 and SH2 binding sites and does not affect the dynamic independence of the two domains. Consequently, the interaction shows no enhancement by an avidity effect. Such an interaction may have evolved to gain specificity through an extended recognition site while maintaining rapid dissociation after signaling.

Legend

Protein

Chemical

Disease

Primary Citation of related structures